+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 8 Actively Recruiting clinical trials

I

Actively Recruiting

Researchers are investigating autoinflammatory diseases AID, which involve recurring inflammatory episodes without infection, cancer, or adaptive immune system problems. This study focuses on both monogenic hereditary periodic syndromes and polygenic or multifactorial AID, including rare conditions like Behets disease, Still disease, Schnitzlers disease, PFAPA syndrome, chronic recurrent multifocal osteomyelitis, non-infectious uveitis and scleritis, among others. The goal is to gather detailed data to improve understanding and management of these rare diseases through an international collaboration. The study uses the AIDA registry, a secure online platform for collecting demographic, genetic, clinical, laboratory, radiologic, and therapeutic information. Data are gathered retrospectively and prospectively during routine clinical visits scheduled every 3-6 months. Eleven registries focus on different AID conditions, enabling comprehensive data collection to identify clinical patterns, treatment impacts, and long-term outcomes over a period of at least 10 years. Participants provide information during their usual care visits, allowing researchers to track changes in disease activity, organ involvement, inflammatory markers, visual function, pain levels, fatigue, fertility, and socioeconomic factors. The study monitors these outcomes over multiple timepoints up to 120 months. Data privacy is ensured by pseudonymizing patient information. This registry supports multiple clinical studies and aims to enhance knowledge, awareness, and future research on autoinflammatory diseases worldwide.

All AgesAll Genders
112 locations
O

Actively Recruiting

This research focuses on emergency departments EDs, which provide initial clinical assessment and treatment for patients with acute conditions. EDs often face high patient volumes leading to crowding, which can reduce care timeliness and effectiveness and increase mortality. Many ED visits are by patients arriving on their own, often for non-urgent issues, and improving patient awareness about ED roles and neighboring ED situations may reduce these visits. Additionally, the study addresses the need for emergency staff to have real-time information on patient flow to manage bottlenecks efficiently and support health policymakers in monitoring epidemiological trends. The study observes the use of a multipurpose dashboard designed to empower patients and assist emergency physicians and nurses by providing live data from various information systems. This dashboard aims to inform about ED crowding, waiting times for tests and consultations, and other operational factors without involving any intervention. The study period covers September 2024 through September 2027, focusing on the dashboards monitoring capabilities. Participants are adults who attend the emergency department between January and December 2025. The study collects data continuously during this period, tracking the dashboards effectiveness in providing situational awareness and supporting decision-making. Researchers evaluate the dashboards impact on emergency department operations and patient flow, with key outcomes measured throughout the study duration. The total participation involves observation and data collection without intervention, lasting until study completion in early 2027.

Age: 18Years +All Genders
2 locations
D

Actively Recruiting

Healthy Volunteer

Researchers are developing and validating a language model called eCREAMLM designed to interpret emergency department electronic health records EHRs from adult patients treated between 2021 and 2023. This observational, retrospective study aims to see if the language model can accurately extract relevant information from free-text medical notes for research and clinical analysis across six languages. The study involves multiple centers across several European countries and addresses challenges in emergency medicine research due to high patient volume and limited staff for data collection. The eCREAMLM model will be created by training and fine-tuning existing open-source language models on billions of medical texts and millions of free-text notes from hospital records. Expert physicians will annotate thousands of clinical notes to guide the fine-tuning process. Once developed, the models accuracy will be validated by comparing its data extraction against physician annotations in 1,000 clinical notes. Data will be anonymized and pooled by language to protect patient privacy. Participants contribute by having their anonymized emergency department medical notes included in the study database. The researchers will analyze how well the language model fills out a virtual case report form compared to experts, using statistical measures of agreement. This process requires no active participation from patients. The study is expected to run until September 2027, with outcomes measured at one month after validation starts.

Age: 18Years +All Genders
8 locations
C

Actively Recruiting

Researchers are evaluating the use of intracoronary optical coherence tomography OCT guidance compared to angiography-only guidance during percutaneous coronary intervention PCI to treat coronary in-stent restenosis ISR. ISR remains a challenge despite advances in drug-eluting stents, and this trial aims to understand whether OCT can improve acute PCI outcomes by providing more detailed imaging guidance. The study is a randomized, multicenter, non-blinded trial including patients with acute coronary syndrome or stable ischemic heart disease who have ISR requiring PCI. Participants will be randomly assigned to one of two groups PCI guided by OCT plus angiography or PCI guided by angiography alone. In the OCT group, operators perform at least one OCT imaging run before and after PCI and may perform additional OCT runs during the procedure. In the angiography-only group, operators perform PCI guided by angiography, but OCT imaging is also done before and after PCI without the operator seeing the results to allow outcome comparison. Operators use standard PCI tools and techniques at their discretion in both groups. During the study, participants undergo diagnostic angiography followed by PCI with assigned imaging guidance. Researchers will assess the cross-sectional area of the treated coronary segment before and after PCI using imaging techniques. Additional data collected include the number of PCI maneuvers, intracoronary devices used, and quantitative flow ratio values. Participants will be followed for one year to monitor major adverse cardiovascular events. The total participation period includes the PCI procedure and follow-up evaluations up to one year post-procedure.

Age: 18Years - 99YearsAll GendersPhase Not Applicable
12 locations
E

Actively Recruiting

Researchers are studying mild traumatic brain injury TBI, a common reason for emergency department visits. The study focuses on how brain computed tomography CT scans are used to detect brain injuries in patients with mild TBI. It aims to analyze the variability of CT scan use across Italian emergency departments, evaluate existing scoring systems that guide CT use, and develop a new model to better predict patient outcomes after mild head trauma. The study observes adult patients with mild TBI who present to emergency departments. Researchers will collect data on CT scan use and assess the accuracy of current clinical decision tools like the Canadian CT Head Rule and NICE guidelines. They will then work to create an improved scoring system to help doctors decide when CT scans are necessary, aiming to reduce unnecessary radiation exposure and healthcare costs. Participants will be monitored from September 2025 through August 2027 with data collected on CT scan usage and patient outcomes. The study will validate existing scores between September 2026 and August 2027 and develop a new predictive score by August 2027. Researchers will review patient data, including Glasgow Coma Scale scores, to measure how well the new tool predicts clinically relevant events. The total study duration spans from January 2026 to August 2027.

Age: 18Years +All Genders
59 locations
O

Actively Recruiting

Researchers are studying how emergency departments EDs across European centers decide to hospitalize patients. The goal is to create a reliable predictive model that estimates each patients chance of being admitted based on clinical conditions and other factors. This model will help compare each EDs hospitalization rates fairly by adjusting for differences in patient and department characteristics. The study is observational and retrospective, involving no interventions or treatments. It involves collecting and analyzing data from adults who visited EDs between January 2021 and December 2023. Two separate databases will be created between September 2024 and September 2025. Following this, multivariable models and adjusted comparisons will be developed from September 2025 to September 2026. Participants data from emergency visits are analyzed to build and validate the predictive model. Researchers will measure how well this model can estimate expected hospitalization rates for each ED and compare them to actual rates. The study spans from September 2025 through February 2027, focusing on quality of care by benchmarking ED performance while considering patient and operational conditions.

Age: 18Years +All Genders
2 locations
C

Actively Recruiting

Researchers are comparing two types of drug-coated balloons, Selution sirolimus coated balloon and SeQuent Please Neo paclitaxel coated balloon, for treating new coronary artery lesions in medium-small vessels sized between greater than 2.00 mm and 3.00 mm. The study aims to evaluate differences in artery diameter improvement Net Gain and blood flow measurement Fractional Flow Reserve at 12 months after treatment. This multicenter, randomized study focuses on patients with small vessel coronary artery disease and stable or stabilized heart conditions. Participants will receive angioplasty using one of the two drug-coated balloons after successful lesion preparation. Patients are randomized 11 to either the sirolimus or paclitaxel balloon groups, stratified by balloon length less than 30 mm or 30 mm and longer. Other non-study lesions may be treated with standard devices if needed. Follow-ups include phone calls at 1 and 6 months, with an angiographic and blood flow assessment at 12 months at the original treatment center. During the study, participants will undergo imaging assessments before and after the procedure and at one year to measure artery narrowing and blood flow. Measurements include quantitative coronary angiography and fractional flow reserve. Dual antiplatelet therapy is required for at least one month post-procedure, followed by aspirin alone indefinitely. Researchers will monitor device and procedure success, heart-related events, and vessel health throughout the 12-month period.

Age: 18Years +All GendersPhase Not Applicable
10 locations
I

Actively Recruiting

Researchers are creating a large registry of patients with ATTR amyloidosis to better understand the diseases natural history in a real-world setting. This study aims to collect data from diagnosis and during follow-up to develop and validate models that predict outcomes and response criteria at any stage of the disease. The registry also promotes data sharing and collaboration among amyloidosis experts and physicians nationwide, improving diagnosis and management of systemic amyloidosis. The study involves an online registry tool accessible to healthcare providers, facilitating data entry and sharing. This network allows physicians to request diagnostic support from the Amyloidosis Research and Treatment Center ARTC, enhancing patient care through expert collaboration. The registry collects ongoing data during patient follow-up at participating centers. Participants contribute by allowing their clinical data to be included in the registry, either prospectively or retrospectively if they have given informed consent. Researchers will monitor the establishment and use of the online data-sharing tool over five years. The study does not involve experimental treatments but focuses on observation and data collection to improve understanding and management of ATTR amyloidosis.

Age: 18Years - 99YearsAll Genders
30 locations